# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4617689 | B | Inhibition of Klebsiella pneumoniae KP1009 CTX-M-15 assessed as minimum concentration of compound required to reduce the MIC of aztreonam to 4 ug/ml | Klebsiella pneumoniae | 65 | assay format | Scientific Literature | ||
2. | ALA4617692 | B | Inhibition of Klebsiella pneumoniae KP1004 KPC-2 assessed as minimum concentration of compound needed to reduce the MIC of aztreonam to 4 ug/ml | Klebsiella pneumoniae | 66 | single protein format | Scientific Literature | ||
3. | ALA4617693 | B | Inhibition of Enterobacter cloacae ECL1002 AmpC assessed as minimum concentration of compound needed to reduce the MIC of aztreonam to 4 ug/ml | Enterobacter cloacae | 65 | assay format | Scientific Literature | ||
4. | ALA4617694 | B | Inhibition of Klebsiella pneumoniae KP1081 NDM-1 assessed as minimum concentration of compound required to reduce the MIC of biapenem to 1 ug/ml | Klebsiella pneumoniae | 55 | assay format | Scientific Literature | ||
5. | ALA4617695 | B | Inhibition of Klebsiella pneumoniae KP1054 VIM-1 assessed as minimum concentration of compound required to reduce the MIC of biapenem to 1 ug/ml | Klebsiella pneumoniae | 54 | assay format | Scientific Literature | ||
6. | ALA4617696 | B | Inhibition of Pseudomonas aeruginosa PAM 2035 AmpC assessed as minimum concentration of compound needed to reduce the MIC of aztreonam to 4 ug/ml | Pseudomonas aeruginosa | 48 | assay format | Scientific Literature | ||
7. | ALA4617697 | B | Inhibition of Klebsiella pneumoniae KP1160 IMP-26 assessed as minimum concentration of compound needed to reduce the MIC of meropenem to 1 ug/ml | Klebsiella pneumoniae | 37 | assay format | Scientific Literature | ||
8. | ALA4617698 | B | Inhibition of Escherichia coli ECM6625 SHV-5 assessed as minimum concentration of compound needed to reduce the MIC of aztreonam to 4 ug/ml | Escherichia coli | 26 | assay format | Scientific Literature | ||
9. | ALA4617699 | B | Inhibition of Escherichia coli ECM6619 TEM-10 assessed as minimum concentration of compound needed to reduce the MIC of aztreonam to 4 ug/ml | Escherichia coli | 26 | assay format | Scientific Literature | ||
10. | ALA4617700 | B | Inhibition of Acinetobacter baumannii AB1053 OXA-72 assessed as minimum concentration of compound needed to reduce the MIC of meropenem to 8 ug/ml | Acinetobacter baumannii | 26 | assay format | Scientific Literature | ||
11. | ALA4617701 | B | Inhibition of Acinetobacter baumannii AB1054 OXA-23 assessed as minimum concentration of compound needed to reduce the MIC of meropenem to 8 ug/ml | Acinetobacter baumannii | 26 | single protein format | Scientific Literature | ||
12. | ALA4617723 | A | Oral bioavailability in rat | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
13. | ALA4617771 | A | Drug metabolism in dog assessed as oxidative-deboronation by measuring 2-hydroxy-3-(2-hydroxyethyl)-6-methoxy-benzoic acid formation | Canis lupus familiaris | 1 | assay format | Scientific Literature | ||
14. | ALA4617772 | A | Drug metabolism in monkey assessed as oxidative-deboronation by measuring 2-hydroxy-3-(2-hydroxyethyl)-6-methoxy-benzoic acid formation | Macaca mulatta | 1 | assay format | Scientific Literature |